Edwards Lifesciences (EW) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed Medtronic (MDT) over the past year, gaining 11.8% versus a loss of 13.0%. Over five years, EW leads with a -23.5% price change compared with -32.7% for MDT. Medtronic is the larger company by market cap ($109.38 billion vs $49.44 billion), about 2.2 times the size, while Edwards Lifesciences is growing revenue faster (+11.5% vs +8.4%).
On valuation, Medtronic trades at a lower forward P/E (13.3x vs 25.4x for Edwards Lifesciences). Medtronic pays a dividend yielding 3.33%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 13.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | MDT |
|---|---|---|
| Share price | $85.78 | $85.51 |
| Market cap | $49.44B | $109.38B |
| 1-day change | -0.81% | -1.81% |
| YTD return | +0.62% | -10.98% |
| 1-year return | +11.81% | -13.04% |
| 5-year return | -23.52% | -32.73% |
| P/E ratio (TTM) | 51.06 | 21.01 |
| Forward P/E | 25.40 | 13.33 |
| EPS (TTM) | $1.68 | $4.07 |
| Dividend yield | 0.00% | 3.33% |
| Annual dividend | $0.00 | $2.85 |
| Revenue (latest FY) | $6.07B | $36.36B |
| Revenue growth (YoY) | +11.55% | +8.43% |
| Net income (latest FY) | $1.07B | $4.80B |
| Gross margin | 78.01% | 65.02% |
| Operating margin | 20.84% | 17.78% |
| Net margin | 17.69% | 13.20% |
| 52-week high | $96.29 | $106.33 |
| 52-week low | $72.30 | $73.31 |
| Distance from 52-week high | -10.91% | -19.58% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.86% | +22.14% |
| Average volume | 3.82M | 10.71M |
| Shares outstanding | 576.40M | 1.28B |
| Employees | 16,000 | 95,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medtronic is about 2.2 times larger than Edwards Lifesciences by market value ($109.38B vs $49.44B).
- EW has outperformed MDT by 24.8 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (51.1x vs 21.0x trailing P/E).
- Medtronic offers a meaningfully higher dividend yield (3.33% vs 0.00%).
- The two companies sit in different sectors: Edwards Lifesciences in Healthcare and Medtronic in Health Care.
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Healthcare · Medical Devices · 16,000 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
EW vs MDT FAQ
Which is bigger, Edwards Lifesciences or Medtronic?
Medtronic (MDT) is larger, with a market capitalization of $109.38B compared with $49.44B for Edwards Lifesciences (EW).
Which stock has performed better over the past year, EW or MDT?
EW returned +11.81% over the past 12 months, compared with -13.04% for MDT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or MDT?
MDT has the lower trailing P/E at 21.0, versus 51.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Medtronic?
Medtronic pays a dividend yielding 3.33%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Medtronic in the same industry?
No. Edwards Lifesciences is in the Healthcare sector, while Medtronic is in Health Care.